Merck's $11.5 Billion Bet on Its Next Big Drug Finally Arrives


The newly approved drug, which treats potentially fatal pulmonary arterial hypertension, is estimated to ring up as much as $7.5 billion in yearly sales.

Source link

Leave a Comment